Kazura J W, Cicirello H, McCall J W
J Immunol. 1986 Feb 15;136(4):1422-6.
The development of immunologic methods to reduce transmission of human lymphatic filariasis depends on measures that will enhance the host's ability to eliminate infective larvae, adult worms, or blood-borne microfilariae (mf). The present study was designed to assess the capacity of a crude extract of Brugia malayi mf to decrease the level of microfilaremia and adult worm burden in jirds inoculated with infective larvae, and to identify the filarial antigens that elicit antibody responses in these animals. Thirty weeks after subcutaneous inoculation with 75 infective larvae, 100% of control jirds were patent (i.e., had microfilaremia) compared with 60% of the group immunized with 10 micrograms of crude microfilarial extract (p less than 0.05). In addition, microfilaremia was lower in patent immunized animals compared with controls (p less than 0.05). The mean total number of adult female B. malayi per jird recovered at necropsy in control animals was 16.0 vs 7.0 in immunized jirds (p less than 0.05). Serum of immunized jirds contained anti-mf antibodies with an end titer of 1:8000, a value similar to that of animals with chronic B. malayi infection. Microfilarial antigens of Mr approximately 150,000, 75,000, 42,000, and 25,000 were identified in immunoblotting studies by reactivity with antibodies in sera of immunized jirds. Antibodies induced by immunization with microfilarial extract were not specific for this stage of the parasite life cycle, as jird anti-mf antibodies reacted with a Mr approximately 150,000 and several Mr 50,000 to 110,000 antigens derived from immature and mature adult parasites of both sexes. These data indicate that immunization of jirds with a water soluble microfilarial extract enhances the host's ability to eliminate adult worms and blood-borne mf. The filarial antigens that induce antibodies in immunized jirds have been identified.
开发用于减少人类淋巴丝虫病传播的免疫方法,取决于能增强宿主消除感染性幼虫、成虫或血源性微丝蚴(mf)能力的措施。本研究旨在评估马来布鲁线虫mf粗提物降低接种感染性幼虫的沙鼠体内微丝蚴血症水平和成虫负荷的能力,并鉴定在这些动物中引发抗体反应的丝虫抗原。皮下接种75条感染性幼虫30周后,100%的对照沙鼠出现虫血症(即有微丝蚴血症),而用10微克微丝蚴粗提物免疫的组中有60%出现虫血症(p<0.05)。此外,出现虫血症的免疫动物的微丝蚴血症水平低于对照组(p<0.05)。尸检时,对照动物每条沙鼠回收的马来布鲁线虫成年雌虫的平均总数为16.0条,而免疫沙鼠为7.0条(p<0.05)。免疫沙鼠的血清含有抗mf抗体,最终效价为1:8000,这一数值与慢性马来布鲁线虫感染动物的数值相似。在免疫印迹研究中,通过与免疫沙鼠血清中的抗体反应,鉴定出分子量约为150,000、75,000、42,000和25,000的微丝蚴抗原。用微丝蚴提取物免疫诱导的抗体并非针对寄生虫生命周期的这一阶段具有特异性,因为沙鼠抗mf抗体与分子量约为150,000以及来自未成熟和成熟雌雄成虫的几种分子量50,000至110,000的抗原发生反应。这些数据表明,用水溶性微丝蚴提取物免疫沙鼠可增强宿主消除成虫和血源性mf的能力。已鉴定出在免疫沙鼠中诱导抗体的丝虫抗原。